Dimethylformamide → 4-(1-Methyl-2-oxo-2-phenylethyl)-1-piperazinecarboxylic acid, 1,1-dimethylethyl Ester

HRID 38273

Reaktionsgleichung

Reaktionsgleichung von HRID 38273
[C:1]([N:8]1[CH2:13][CH2:12][NH:11][CH2:10][CH2:9]1)([O:3][C:4]([CH3:7])([CH3:6])[CH3:5])=[O:2].CN(C(ON1N=N[C:24]2[CH:25]=[CH:26][CH:27]=N[C:23]1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[C:38]1([CH:44](C)[C:45](O)=[O:46])C=CC=CC=1.[CH3:49]N(C=O)C>C(OCC)C>[CH3:38][CH:44]([N:11]1[CH2:10][CH2:9][N:8]([C:1]([O:3][C:4]([CH3:7])([CH3:6])[CH3:5])=[O:2])[CH2:13][CH2:12]1)[C:45](=[O:46])[C:23]1[CH:24]=[CH:25][CH:26]=[CH:27][CH:49]=1

Komponenten

6

Versuchsvorschrift

To N-BOC-piperazine (0.373 g) in DMF (10 ml) was added HATU (1.14 g) followed by 2-phenylpropionic acid (0.30 ml) and the reaction stirred at RT for 16 h followed by 60° C. for 1 h. The reaction was cooled to RT, then diluted with diethyl ether, washed with water (×3), 2M HCl (×2), saturated aq. NaHCO3 (aq) (×2), dried (Na2SO4) and concentrated in vacuo to give the sub-titled compound (0.25 g).

Aufarbeitung

  1. waitfollowed by 60° C. for 1 h
  2. temperatureThe reaction was cooled to RT
  3. washwashed with water (×3), 2M HCl (×2), saturated aq. NaHCO3 (aq) (×2)
  4. dry with materialdried (Na2SO4)
  5. concentrationconcentrated in vacuo

Quellen und Nachweise

ORD-Eintrag
ord-16acc7c4cde945e59cce37a822ebe269
Quelldatensatz
uspto-grants-2013_09
Patentnummer
US08524715B2

Verknüpfte Notizen

Wird geladen…